AGER and COVID-19: In summary, HMGB1 may be involved in COVID-19 through at least two mechanisms: one is TLR4-mediated cytokine storm in immune cells, and the other is AGER-mediated ACE2 expression in alveolar epithelial cells (Figure 4C).